The present disclosure provides a formulation for inflammatory skin conditions comprising about 0.05% to 10% by weight of colloidal oatmeal, about 5% about 30% by weight of coconut oil, about 0.25% to about 5% by weight of a corticosteroid, and a pharmaceutically acceptable carrier, emollient and/or diluent. The formulation further comprises in certain embodiments ferulic acid, petrolatum, a wax, and/or a silicone. The present disclosure further provides methods of treating, preventing or reducing the symptoms of inflammatory skin conditions, including eczema, psoriasis and seborrheic dermatitis, comprising topically administering to an affected area of skin a therapeutically effective amount of the formulations disclosed herein.
